Moderna
PulseAugur coverage of Moderna — every cluster mentioning Moderna across labs, papers, and developer communities, ranked by signal.
- 2026-08-06 product_launch The FDA approved Moderna's mRNA flu vaccine, mFlusiva (mRNA-1010), for adults aged 50 and over. source
- 2026-06-22 regulatory The FDA has unanimously approved Moderna's mRNA vaccine. source
- 2026-06-01 funding Moderna received $50 million to develop an mRNA vaccine against the Bundibugyo strain of Ebola. source
3 day(s) with sentiment data
-
Moderna's mRNA flu vaccine mFLUSIVA gains FDA approval for adults 50+
Moderna has received FDA approval for its mRNA-based flu vaccine, named mFLUSIVA. This vaccine is now authorized for use in all adults aged 50 and older. The approval followed a review process that was described as a "r…
-
FDA approves Moderna's mRNA flu vaccine after initial review refusal · 2 sources tracked
The U.S. Food and Drug Administration (FDA) has approved Moderna's mRNA-based flu vaccine, mFlusiva (mRNA-1010), for adults aged 50 and over. This approval follows an initial refusal by the FDA to review the application…
-
Investors eye AI giants Anthropic, OpenAI for next trillion-dollar IPOs
Investors are closely watching for potential IPOs from AI companies like Anthropic and OpenAI, drawing parallels to SpaceX's recent massive debut. While the excitement around these companies is high, financial experts a…
-
FDA Approves Moderna mRNA Vaccine; Logarithms Explored
The FDA has unanimously approved Moderna's mRNA vaccine, a decision that signifies a major advancement in mRNA technology and is anticipated to significantly influence the healthcare sector. Separately, the concept of l…
-
New Limit therapy boosts liver repair in mice, human trials next year
New Limit has developed a single-dose cellular reprogramming therapy that significantly improves survival rates in mice with alcohol-induced liver damage. This therapy restores the liver's youthful resilience and regene…
-
AI tools streamline small business admin; Anthropic eyes IPO
Small businesses can now leverage AI for administrative tasks such as accounting, design, and market research, according to MIT Technology Review. The article highlights how AI models can handle basic work like organizi…
-
Moderna gets $50M for Ebola vaccine; Pixel Watch 5 possibly leaked
Moderna has received $50 million to develop an mRNA vaccine targeting the Bundibugyo strain of Ebola. This initiative aims to accelerate vaccine development amidst a current Ebola outbreak. Separately, the Pixel Watch 5…
-
New TMLE method improves vaccine effectiveness analysis with missing data
Researchers have developed a new targeted maximum likelihood estimation (TMLE) approach for analyzing test-negative design (TND) studies, particularly those with missing data in exposure variables. This semiparametric l…
-
FDA Commissioner Marty Makary Resigns Amidst Controversy and Upheaval
FDA Commissioner Dr. Marty Makary has resigned after a turbulent 13-month tenure marked by organizational upheaval and controversies. His initiatives to streamline drug approvals and increase transparency faced criticis…
-
Moderna partners with OpenAI to accelerate drug discovery with ChatGPT Enterprise
Moderna has partnered with OpenAI to integrate ChatGPT Enterprise across its operations, aiming to accelerate the development of mRNA medicines. The pharmaceutical company has focused on a comprehensive workforce transf…